Complaint: 17/362

Tumerix, Digital Marketing

Details

Complainants
M. Honeychurch
advertisers
Turmerix
Year
2017
Media
Digital Marketing
Product
Health and Beauty
Clauses
Decision
Upheld / Settled
ASA Links
Website Listing
Decision Document

Document

2017_36200.png



COMPLAINT NUMBER 17/362

COMPLAINANT M. Honeychurch ADVERTISER Turmerix ADVERTISEMENT Tumerix, Digital Marketing DATE OF MEETING 20 October 2017

OUTCOME Settled

Advertisement: The website advertisement for Turmerix, https://buyturmerix.com, listed the various health benefits of Turmerix, a turmeric product containing curcumin.

The Chair ruled the complaint was Settled

Complainant, M Honeychurch, said: On the webpage titled "Some Health Benefits Of

Turmeric", Turmerix NZ, with large section titles talking of "Cancer", "Liver Disease", "Type 2

Diabetes", "Alzheimers Disease And Dementia" and "Tendonitis and Arthritis". Therapeutic claims are made.

These claims appear to breach the ASA's Therapeutic and Health Advertising Code, as they

make unsubstantiated claims about the efficacy of Turmerix - a turmeric product containing curcumin.

Rule 2(a) has been breached, as these claims of efficacy are not supported by good quality evidence. The "studies" that are mentioned in passing to support the claims are not properly referenced, and are unlikely to be of a high enough quality to prove efficacy. In fact, it's likely

that the studies are false positives, as explained in this article:

https://www.smithsonianmag.com/smart-news/turmeric-may-taste-good-its-not-cure-all-1809

61786/

The relevant provisions were Therapeutic and Health Advertising Code - Principle 1, Principle 2, Rule 2(a).

The Chair noted the Complainant's concern that the Advertiser's website contained unsubstantiated claims about the benefits of Turmerix, a turmeric product containing curcumin, which were misleading.

The Chair acknowledged the Advertiser had made changes to the website, removing references which were of concern and undertaking to work with the Secretariat regarding future content.

Given the Advertiser's co-operative engagement with the process and the self-regulatory action taken in amending the website, the Chair said that it would serve no further purpose to place the matter before the Complaints Board. The Chair ruled that the matter was settled.

Chai r 's Ruling: Complaint Settled